- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 139.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 140.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 142.49M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $198.48M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $418.93M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $415.9M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $9.36B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $9.33B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $121.23M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $187.23M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $53.26M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.49B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.61B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.41B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.36B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $22.13B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.19B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.33 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.66 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.33 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.66 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $22.08M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $19.78M |
| Net Income | Q1 2026 · Mar 31, 2026 | $325.73M |
| Net Income | Q1 2026 · Mar 31, 2025 | $236.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $517.49M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $496.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.83M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.74M |